+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia-Pacific Contraceptive Market 2019-2027

  • ID: 4772802
  • Report
  • Region: Asia Pacific
  • 103 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 3

FEATURED COMPANIES

  • Afaxys, Inc.
  • Allergan Inc.
  • Church & Dwight Co., Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • Okamoto Industries, Inc
  • MORE
Market Outlook

In its research report, the author has concluded that the Asia-Pacific contraceptives market is projected to rise at a CAGR of 7.70% during the forecast period of 2019-2027. The region, comprising of countries such as India, Japan, China, South Korea, New Zealand, Australia, ASEAN and the rest of APAC countries has a tremendous growth potential.

The main drivers fueling the growth of this industry are the rising incidences of individuals contracting STIs and popularity of highly-effective oral contraceptive pills. Overpopulation is a grave issue faced by developing countries in this region, and to combat this problem, the governments have initiated various programs to raise awareness about the importance of birth control. Moreover, women are now more open to adopting newer methods of contraception. Developing effective methods to overcome the occurrence of side-effects due to contraceptive consumption will further boost the market.

Information about the market definition, key insights, Pestel outlook, Porter's five force analysis, regulatory outlook, and the market attractiveness index has been included in the report.

The unmet needs for the availability of effective contraception techniques due to poor medical facilities allow contraceptive manufacturers to establish their base into the Asia-Pacific market. New and improved technical advancements in contraceptive drugs and devices have made them even more appealing to the population. However, contraceptives are met with a lack of acceptance in emerging economies due to religious and cultural norms followed by a certain section of the population in developing countries.

Competitive Outlook

The prominent companies in the contraceptives manufacturing market are SMB Corporation, Pregna, Pfizer, Inc., Ocon Medical, Ltd., Merck & Co., Inc., Allergan, Inc., Cooper Surgical, Inc., Mayer Laboratories, Inc., Apothecus Pharmaceutical Corporation, Church & Dwight Co., Inc., Reckitt Benckiser PLC, Agile Therapeutics, Okamoto Industries, Inc., Bayer AG, Afaxys, Inc., Teva Pharmaceutical Industries, Ltd. and Melbea.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Afaxys, Inc.
  • Allergan Inc.
  • Church & Dwight Co., Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • Okamoto Industries, Inc
  • MORE
1. Contraceptive Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threat of New Entrants
2.2.2. Threat of Substitute
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Threat of Competitive Rivalry
2.3. Regulatory Outlook
2.4. Pestel Outlook
2.5. Market Attractiveness Index
2.6. Market Player Positioning
2.7. Key Insights
2.7.1. Oral Contraceptive Are the Majorly Used Contraceptive Drugs
2.7.2. Condoms Are the Widely Used Contraceptives Device
2.7.3. Age Group of 15–24 Years Are the Major Revenue Contributors to the Asia-Pacific Contraceptive Market
2.8. Market Drivers
2.8.1. Growing Cognizance For Contraceptives
2.8.2. Increasing Usage of Oral Contraceptives to Evade Unplanned Pregnancy
2.8.3. Surge in the Initiatives of Government and Ngo
2.8.4. Growing Awareness About Std
2.9. Market Restraints
2.9.1. Side Effects Restricting the Growth of Contraceptives
2.9.2. Limited Access to Contraceptives
2.10. Market Opportunities
2.10.1. Rising Disposable Income in Emerging Economies
2.10.2. Unmet Medical Needs in the Emerging Economies
2.10.3. Technological Advancements
2.11. Market Challenges
2.11.1. Lack of Acceptance of Society

3. Contraceptive Market Outlook - By Education
3.1. Less Than High School
3.2. High School Graduate
3.3. College Graduate
3.4. Other College Degrees

4. Contraceptive Market Outlook - By Age Group
4.1. 15–24 Years
4.2. 25–34 Years
4.3. 35–44 Years
4.4. Above 44 Years

5. Contraceptive Market Outlook - By End User
5.1. Households
5.2. Clinics
5.3. Hospitals

6. Contraceptive Market Outlook - By Drugs and Devices
6.1. Contraceptives Drugs
6.1.1. Oral Contraceptive Pills
6.1.2. Injectable Contraceptives
6.1.3. Topical Contraceptives
6.2. Contraceptive Devices
6.2.1. Male Condoms
6.2.2. Female Condoms
6.2.3. Diaphragms
6.2.4. Contraceptive Sponges
6.2.5. Vaginal Rings
6.2.6. Subdermal Implants
6.2.7. Intra-Uterine Devices
6.2.7.1. Copper Intra-Uterine Devices
6.2.7.2. Hormonal Intra-Uterine Devices

7. Contraceptive Market - Regional Outlook
7.1. Asia-Pacific
7.1.1. Country Analysis
7.1.1.1. Japan
7.1.1.2. China
7.1.1.3. India
7.1.1.4. Australia & New Zealand
7.1.1.5. South Korea
7.1.1.6. Asean Countries
7.1.1.7. Rest of Asia-Pacific

8. Competitive Landscape
8.1. Company Profiles
8.1.1. Allergan Inc.
8.1.2. Bayer Ag
8.1.3. Melbea
8.1.4. Pregna
8.1.5. Pfizer, Inc.
8.1.6. Church & Dwight Co., Inc.
8.1.7. Afaxys, Inc.
8.1.8. Apothecus Pharmaceutical Corporation
8.1.9. Cooper Surgical Inc
8.1.10. Okamoto Industries, Inc
8.1.11. Mayer Laboratories, Inc.
8.1.12. Agile Therapeutics
8.1.13. Merck & Co., Inc.
8.1.14. Reckitt Benckiser Plc
8.1.15. Smb Corporation
8.1.16. Teva Pharmaceutical Industries Ltd.
8.1.17. Ocon Medical Ltd

9. Methodology & Scope
9.1. Research Scope
9.2. Sources of Data
9.3. Research Methodology

List of Tables
Table 1 Asia-Pacific Contraceptive Market 2019-2027 ($ Million)
Table 2 Contraceptive Market Player Positioning Outlook 2017
Table 3 Asia-Pacific Contraceptive Market By Education 2019-2027 ($ Million)
Table 4 Asia-Pacific Contraceptive Market By Age Group 2019-2027 ($ Million)
Table 5 Asia-Pacific Contraceptive Market By End User 2019-2027 ($ Million)
Table 6 Asia-Pacific Contraceptive Market By Drugs and Devices 2019-2027 ($ Million)
Table 7 Asia-Pacific Contraceptives Drugs Market By Type 2019-2027 ($ Million)
Table 8 Asia-Pacific Oral Contraceptive Pills Market 2019-2027 ($ Million)
Table 9 Asia-Pacific Injectable Contraceptives Market 2019-2027 ($ Million)
Table 10 Asia-Pacific Topical Contraceptives Market 2019-2027 ($ Million)
Table 11 Asia-Pacific Contraceptive Devices Market By Type 2019-2027 ($ Million)
Table 12 Asia-Pacific Intra-Uterine Devices Market By Type 2019-2027 ($ Million)
Table 13 Asia-Pacific Contraceptive Market By Country 2019-2027 ($ Million)

List of Figures
Figure 1 Asia-Pacific Contraceptive Market 2019-2027 ($ Million)
Figure 2 Porter's Five Force Model
Figure 3 Asia-Pacific Contraceptive Market By Less Than High School 2019-2027 ($ Million)
Figure 4 Asia-Pacific Contraceptive Market By High School Graduate 2019-2027 ($ Million)
Figure 5 Asia-Pacific Contraceptive Market By College Graduate 2019-2027 ($ Million)
Figure 6 Asia-Pacific Contraceptive Market By Other College Degrees 2019-2027 ($ Million)
Figure 7 Asia-Pacific Contraceptive Market By 15–24 Years 2019-2027 ($ Million)
Figure 8 Asia-Pacific Contraceptive Market By 25–34 Years 2019-2027 ($ Million)
Figure 9 Asia-Pacific Contraceptive Market By 35–44 Years 2019-2027 ($ Million)
Figure 10 Asia-Pacific Contraceptive Market By Above 44 Years 2019-2027 ($ Million)
Figure 11 Asia-Pacific Contraceptive Market By Households 2019-2027 ($ Million)
Figure 12 Asia-Pacific Contraceptive Market By Clinics 2019-2027 ($ Million)
Figure 13 Asia-Pacific Contraceptive Market By Hospitals 2019-2027 ($ Million)
Figure 14 Asia-Pacific Contraceptive Market By Contraceptives Drugs 2019-2027 ($ Million)
Figure 15 Asia-Pacific Contraceptives Drugs Market By Oral Contraceptive Pills 2019-2027 ($ Million)
Figure 16 Asia-Pacific Contraceptives Drugs Market By Injectable Contraceptives 2019-2027 ($ Million)
Figure 17 Asia-Pacific Contraceptives Drugs Market By Topical Contraceptives 2019-2027 ($ Million)
Figure 18 Asia-Pacific Contraceptive Market By Contraceptive Devices 2019-2027 ($ Million)
Figure 19 Asia-Pacific Contraceptive Devices Market By Male Condoms 2019-2027 ($ Million)
Figure 20 Asia-Pacific Contraceptive Devices Market By Female Condoms 2019-2027 ($ Million)
Figure 21 Asia-Pacific Contraceptive Devices Market By Diaphragms 2019-2027 ($ Million)
Figure 22 Asia-Pacific Contraceptive Devices Market By Contraceptive Sponges 2019-2027 ($ Million)
Figure 23 Asia-Pacific Contraceptive Devices Market By Vaginal Rings 2019-2027 ($ Million)
Figure 24 Asia-Pacific Contraceptive Devices Market By Subdermal Implants 2019-2027 ($ Million)
Figure 25 Asia-Pacific Contraceptive Devices Market By Intra-Uterine Devices 2019-2027 ($ Million)
Figure 26 Asia-Pacific Intra-Uterine Devices Market By Copper Intra-Uterine Devices 2019-2027 ($ Million)
Figure 27 Asia-Pacific Intra-Uterine Devices Market By Hormonal Intra-Uterine Devices 2019-2027 ($ Million)
Figure 28 Japan Contraceptive Market 2019-2027 ($ Million)
Figure 29 China Contraceptive Market 2019-2027 ($ Million)
Figure 30 India Contraceptive Market 2019-2027 ($ Million)
Figure 31 Australia & New Zealand Contraceptive Market 2019-2027 ($ Million)
Figure 32 South Korea Contraceptive Market 2019-2027 ($ Million)
Figure 33 Asean Countries Contraceptive Market 2019-2027 ($ Million)
Figure 34 Rest of Asia-Pacific Contraceptive Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan Inc.
  • Bayer AG
  • Melbea
  • Pregna
  • Pfizer, Inc.
  • Church & Dwight Co., Inc.
  • Afaxys, Inc.
  • Apothecus Pharmaceutical Corporation
  • Cooper Surgical Inc
  • Okamoto Industries, Inc
  • Mayer Laboratories, Inc.
  • AGile Therapeutics
  • Merck & Co., Inc.
  • Reckitt Benckiser plc
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Ocon Medical
Note: Product cover images may vary from those shown
Adroll
adroll